On Thursday, Shares of MGM Resorts International (NYSE:MGM), lost -0.21% to $19.32.
MGM Resorts International, declared that leading independent proxy advisory firm Institutional Shareholder Services Inc. (“ISS”) has issued a report recommending that MGM’s shareholders vote the WHITE proxy card FOR the reelection of all eleven of MGM’s highly qualified director nominees. ISS also specifically recommended that shareholders do not vote for any of the four nominees projected by Land & Buildings (“L&B”). The Company’s 2015 Annual Meeting will be held on May 28, 2015.
In recommending that shareholders support the Company’s entire slate of director nominees, ISS stated in its May 13, 2015 report:
- “As the dissident has not made a compelling case that change at the board level is warranted, votes on the administration card for all administration nominees are warranted.”
- “This does not appear to be a board dismissive of emerging, and sometimes competing, planned alternatives.”
- “It is also noteworthy that the company continues to invest in the future – counting expanding domestically, with the National Harbor and Springfield projects, in addition to internationally – but makes no all-in bet on a single project. Even a major project like MGM Cotai represents less than 15% of enterprise value.”
- “On the REIT issue out of which this contest appears to have sprung, there is […] little evidence indicating the board is unduly resistant to the strategy, or unlikely to take appropriate action if it can enhance shareholder value.”
MGM Resorts International, through its auxiliaries, owns and/or operates casino resorts. It operates through two segments, Wholly Owned Domestic Resorts and MGM China. The company’s casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. Its casino operations comprise slots, table games, and race and sports book wagering.
Shares of MasTec, Inc. (NYSE:MTZ), inclined 0.88% to $17.11, during its last trading session.
MasTec, declared that its senior administration will be in London presenting at the Barclays 2015 Americas Select Investor Conference on Wednesday, May 20th, at about 8:00 a.m. Eastern time. One-on-one meetings with institutional investors and MasTec’s senior administration are also being arranged as a part of the conference.
MasTec, Inc., an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for energy, utility, and communications infrastructure primarily in the United States. It operates in five segments: Communications, Oil and Gas, Electrical Transmission, Power Generation and Industrial, and Other.
At the end of Thursday’s trade, Shares of Sunstone Hotel Investors Inc. (NYSE:SHO), gained 2.49% to $15.63.
Sunstone Hotel Investors, declared results for the first quarter ended March 31, 2015.
First Quarter 2015 Operational Results (as contrast to First Quarter 2014)
- Adjusted Comparable Hotel RevPAR raised 7.0% to $150.12.
- Adjusted Comparable Hotel EBITDA Margins raised 220 basis points to 26.2%.
- Adjusted EBITDA raised 33.1% to $65.7 million.
- Adjusted FFO accessible to common stockholders per diluted share raised 46.7% to $0.22.
- Loss attributable to common stockholders reduced 59.2% to $3.3 million.
- Loss attributable to common stockholders per diluted share reduced 50.0% to $0.02.
Sunstone Hotel Investors, Inc. operates as a real estate investment trust. The firm engages in the acquisition, ownership, asset administration, renovation, and sale of luxury, upper upscale, and upscale full-service hotels in the United States. Its portfolio also comprises mid-scale hotels. Sunstone Hotel Investors was founded in 1995 and is based in Aliso Viejo, California.
Finally, Amgen Inc. (NASDAQ:AMGN), ended its last trade with 2.27% gain, and closed at $161.98.
Amgen, declared voting results from the Company’s Annual Meeting of Stockholders, held in Westlake Village, Calif. About 89 percent of outstanding shares were represented at the meeting.
The director nominees David Baltimore, Frank J. Biondi, Jr., Robert A. Bradway, François de Carbonnel, Vance D. Coffman, Robert A. Eckert, Greg C. Garland, Rebecca M. Henderson, Frank C. Herringer, Tyler Jacks, Judith C. Pelham, Ronald D. Sugar, and R. Sanders Williams were each re-elected to Amgen’s Board of Directors. Each director received at least 92 percent of the votes cast “For.” With the re-election of all of the director nominees, Amgen presently has 13 directors.
With about 99 percent of the votes cast “For,” stockholders ratified Ernst & Young LLP as Amgen’s independent registered public accountants for the year ending Dec. 31, 2015.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
